TransMedics Statistics Share Statistics TransMedics has 34.09M
shares outstanding. The number of shares has increased by 1.42%
in one year.
Shares Outstanding 34.09M Shares Change (YoY) 1.42% Shares Change (QoQ) 0.51% Owned by Institutions (%) 99.99% Shares Floating 32.96M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.84M, so 23% of the outstanding
shares have been sold short.
Short Interest 7.84M Short % of Shares Out 23% Short % of Float 39.52% Short Ratio (days to cover) 6.52
Valuation Ratios The PE ratio is 58.42 and the forward
PE ratio is 38.1.
TransMedics's PEG ratio is
-0.24.
PE Ratio 58.42 Forward PE 38.1 PS Ratio 4.69 Forward PS 5 PB Ratio 9.06 P/FCF Ratio -25.6 PEG Ratio -0.24
Financial Ratio History Enterprise Valuation TransMedics has an Enterprise Value (EV) of 2.25B.
EV / Sales 5.1 EV / EBITDA 32.22 EV / EBIT 46.18 EV / FCF -27.84
Financial Position The company has a current ratio of 8.3,
with a Debt / Equity ratio of 2.27.
Current Ratio 8.3 Quick Ratio 7.52 Debt / Equity 2.27 Debt / EBITDA 7.41 Debt / FCF -6.4 Interest Coverage 2.6
Financial Efficiency Return on Equity is 15.51% and Return on Invested Capital is 4.98%.
Return on Equity 15.51% Return on Assets 4.41% Return on Invested Capital 4.98% Revenue Per Employee $606.51K Profits Per Employee $48.71K Employee Count 728 Asset Turnover 0.55 Inventory Turnover 3.85
Taxes Income Tax 316K Effective Tax Rate 0.88%
Stock Price Statistics The stock price has increased by -24.21% in the
last 52 weeks. The beta is 2.17, so TransMedics's
price volatility has been higher than the market average.
Beta 2.17 52-Week Price Change -24.21% 50-Day Moving Average 117.94 200-Day Moving Average 93.4 Relative Strength Index (RSI) 35.73 Average Volume (20 Days) 1,031,019
Income Statement In the last 12 months, TransMedics had revenue of 441.54M
and earned 35.46M
in profits. Earnings per share was 1.07.
Revenue 441.54M Gross Profit 262.08M Operating Income 37.5M Net Income 35.46M EBITDA 69.95M EBIT 50.19M Earnings Per Share (EPS) 1.07
Full Income Statement Balance Sheet The company has 336.65M in cash and 518.29M in
debt, giving a net cash position of -181.64M.
Cash & Cash Equivalents 336.65M Total Debt 518.29M Net Cash -181.64M Retained Earnings -468.24M Total Assets 890.52M Working Capital 501.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 48.8M
and capital expenditures -129.74M, giving a free cash flow of -80.94M.
Operating Cash Flow 48.8M Capital Expenditures -129.74M Free Cash Flow -80.94M FCF Per Share -2.44
Full Cash Flow Statement Margins Gross margin is 59.36%, with operating and profit margins of 8.49% and 8.03%.
Gross Margin 59.36% Operating Margin 8.49% Pretax Margin 8.1% Profit Margin 8.03% EBITDA Margin 15.84% EBIT Margin 8.49% FCF Margin -18.33%
